We are pleased to announce that SpiroChem will be participating in the DMCCB Basel Symposium 2026, taking place on Thursday, February 5, 2026, in Basel, Switzerland.
Organised by the Swiss Chemical Society – Division of Medicinal Chemistry & Chemical Biology (DMCCB), the Basel Symposium is a well-established scientific event bringing together researchers from academia and industry to discuss current challenges and emerging strategies in medicinal chemistry and chemical biology.
The symposium will feature expert lectures and scientific discussions focused on innovative approaches in drug discovery, molecular design, and translational research, offering a valuable platform for knowledge exchange and collaboration within the Swiss and international scientific community.
Meet Meet our team on-site:
• Christophe Salome – Principal Scientist & R&D Coordinator
• Cédric Fries – Business Development Manager
We look forward to engaging with participants in Basel and discussing how SpiroChem’s expertise in discovery chemistry and addressing challenging targets can contribute to advancing innovative drug discovery programs.
